The high prevalence of substance use among HIV-infected individuals creates numerous challenges to patient care. This study was undertaken in order to understand the impact of substance use on care outcomes for HIV-infected individuals in Manitoba. Clinical records of 564 HIV-infected individuals in care at Health Sciences Centre in Winnipeg, Manitoba were reviewed. Clinical data were extracted from patient charts for substance users (illicit substance users, alcohol abusers and chronic users of opioids or benzodiazepines) and non-users. Substance users and non-users were analysed using chi-square analysis and logistic regression models to compare basic socio-demographic and clinic variables. Chi-square and analysis of variance were used to compare a subset of substance users based on similar socio-demographic and clinical characteristics. Among HIV-infected individuals in Manitoba, 38% were substance users with over-representation by Aboriginals, females, young adults and residents of Winnipeg's core areas. Opioids and benzodiazepines were the most commonly used substances with the majority of substance users having used multiple classes of substances in their lifetime. Substance users were more likely than non-users to have missed clinic appointments. Among substance users, missed appointments were more common among those who self-identified as Aboriginal, female, young adults, residents of Winnipeg's core areas, heterosexuals and those who had abused alcohol or cocaine/crack. Aboriginal substance users were also less likely to achieve viral load suppression compared to non-Aboriginal substance users. With the high prevalence of substance use among HIV-infected individuals in Manitoba, it is important to identify at-risk individuals in order to implement appropriate care strategies and improve treatment adherence and health outcomes.
Introduction
Substance use is the inappropriate consumption of medicines or other materials including prescription and over-the-counter drugs, street drugs, alcohol and tobacco (Miller-Keane & O'Toole, 2003) . In HIV infection, substance use is associated with an increased prevalence of medical and psychiatric comorbidities and results in poorer treatment adherence and clinical outcomes (Altice, Izaman, Soriano, Schechter, & Friedland, 2010; Gonzalez, Barinas, & O'Cleirigh, 2011) . Access to addiction and psychiatric treatment programmes allows HIVinfected substance users to achieve similar adherence as HIV-infected non-substance users (Gonzalez et al., 2011; Malta, Strathdee, Magnanini, & Bastos, 2008) .
Manitoba has among the highest rates of HIV in Canada with more than 1100 people enrolled in care (Manitoba HIV Program, 2011; Public Health Agency of Canada, 2012) . Indigenous populations are over-represented with respect to HIV in Manitoba and Canada, with an infection rate 3.6 times higher than the Canadian general population (Manitoba HIV Program, 2011; Public Health Agency of Canada, 2012) . Although much is known about HIV in Manitoba, there is little knowledge about the substance use patterns and the impact of substance use in this population. A review of patients enrolled in care in the Manitoba HIV Program (MHP) at Winnipeg's Health Sciences Centre (HSC) was conducted to characterise socio-demographic features, substance use patterns and the effect of substance use on care outcomes for HIV-infected persons in Manitoba.
Methods
We conducted a retrospective chart review of HIVinfected patients in care in the MHP, HSC site in Manitoba, Canada. All patients in care during the chart review were included. This study was conducted between June and August 2013 and was approved by the institutional Human Research Ethics Board at the University of Manitoba.
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Data collection
Socio-demographic information and CD4 counts were collected for all participants. Viral load (VL) and substance use history was collected for substance users only. Substance use was defined as one or more of the following since enrolment in the MHP: the use of an illicit substance other than cannabis at least once; the use of prescription benzodiazepines or opioids for four or more consecutive months; being documented as an alcohol abuser. Illicit substances included crack cocaine, heroin and crystal methamphetamine, among others. All participants were 18 years of age or older. Geographic location was mapped to areas within Manitoba and North-western Ontario using the first three digits of each participant's postal code, with subsequent grouping into "urban core" (Winnipeg's Downtown and Point Douglas communities) or "nonurban core" (the remainder of Manitoba and Northwestern Ontario). A missed appointment was defined as having missed a scheduled clinic appointment without notice of absence from 1 January 2012 to 15 August 2013; these data were collected directly from the HSC database.
Analysis
Two sets of analyses were undertaken. The first compared socio-demographic and clinical characteristics between substance users and non-users using chi-square analysis and Kruskal-Wallis tests, where appropriate. Unadjusted (Model 1) and adjusted odds ratios (Model 2) are reported from separate logistic regression models examining the association between the two outcomes of interest (missed appointments and CD4 at presentation) and substance use. Aboriginal ethnicity (First Nations, Inuit and Métis) and substance use appeared to be associated with greater likelihood of missing appointments and were included in multivariate logistic regression analysis (Model 3).
For the second set of analyses, which included substance users only, the association between the outcomes of interest and an expanded set of socio-demographic and clinical characteristics were examined, focusing on types of substance used. Bivariate comparisons between each outcome and socio-demographic, clinical and reported substance use were made using chi-square tests of association or analysis of variance, where appropriate. With the exception of substance use variables, all variables associated with the outcomes at the P < 0.20 level were included in multivariate analyses.
Results
Of the 564 participants, 215 (38%) were substance users. Substance use was associated with age younger than 40, female gender, Aboriginal ethnicity, residence in Winnipeg's core areas and missed clinic appointments (Table 1) . The most prevalent substances were opioids, benzodiazepines, alcohol and cocaine/crack at 74%, 60%, 51% and 39% of substance users, respectively. CD4 counts were available for all but one participant and were not associated with substance use.
Substance use was ongoing among 94% at the time of chart review, while 73% had used multiple classes of substances since presentation. Eighty-six per cent of substance users had been using one or more substances on a daily basis with 68% attributable to non-medically prescribed usage. Medical prescriptions for opioids and benzodiazepines accounted for the entire substance use of 18% of substance users. Illicit opioid use (including heroin) accounted for 14% of all opioid use (data not shown). Table 2 correlates missed clinic appointments with substance use and socio-demographic parameters. Aboriginal substance users were highly likely of missing at least one clinic appointment independent of age, gender or geography.
Female gender, Aboriginal ethnicity, residence in Winnipeg's core areas, heterosexual orientation and the abuse of alcohol or cocaine/crack were associated with missing clinic appointments among substance users (Table 3 ). This correlation persisted for Aboriginals and heterosexuals after adjustment.
Substance users who were Aboriginal or younger than 40 years old were less likely to have ever achieved VL suppression (Table 4) . Seventy-nine per cent of substance users achieved VL suppression at least once.
Discussion
This study is the first to describe substance use patterns among HIV-infected individuals in Manitoba. Thirtyeight per cent of HIV-infected individuals in care at HSC use substances, with higher prevalence among 
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Aboriginals, females, young adults and those residing in Winnipeg's core. Substance users were more likely to miss clinic appointments with Aboriginal substance users at the highest likelihood of missing appointments. Young and Aboriginal substance users were also less likely to attain viral suppression. Identifying at-risk populations improves our ability to effectively treat substance use disorders and improve HIV treatment outcomes including access to and retention in care programmes (Meyer, Althoff, & Altice, 2013) .
The association between substance use and HIV is well documented. Injection drug use accounts for a small proportion of HIV infections in Manitoba, while noninjection drug and alcohol use lead to high-risk behaviours, HIV propagation and comorbidity (Manitoba HIV Program, 2011; Meyer et al., 2013) . Substance use is a predictor of a more rapid HIV disease progression regardless of adherence to antiretroviral therapy (Carrico, 2011) . In the context of this study, substance use is associated with female gender, residence in the downtown area and Aboriginal ethnicity, which may represent the vulnerability to adverse health outcomes for these populations in general. Living in urban core areas, female gender and Aboriginal ethnicity predicted missed clinic appointments while homosexual orientation decreased the likelihood of missed appointments. These factors act together to decrease engagement in care as expressed by the number of missed appointments. Only Aboriginal ethnicity remained as an independent predictor of missed appointments after adjustment for confounders.
The prevalence of non-cannabis substance use among HIV-infected persons in Manitoba is comparable to previous studies (Bing et al., 2001) . Alcohol is the most widely abused substance in Manitoba, though solvents, cannabis, cocaine and opioids are commonly reported (Canadian Community Epidemiology Network on Drug Use, Winnipeg Site Network Team, 2011). The disparity between substances used in the general population and HIV-infected individuals may result from the availability of prescription drug information in Manitoba compared to self-reporting of alcohol and illicit substance use. Thus, alcohol and nonprescription substance use may be generally underreported, especially among those who miss appointments. In contrast to opioids or benzodiazepines where replacement therapy ). AOR, adjusted odds ratio from logistic regression analysis; the analysis is adjusted for each of the confounders included in the model (P b ).
or harm reduction strategies are applied, the effects of alcohol and cocaine on engagement in care need to be further investigated. Substance use disorders are well-known barriers to health care, leading to reluctance or delay in seeking medical treatment, irrespective of health status (McCoy, Metsch, Chitwood, & Miles, 2001) . In this study, appointment adherence dropped with alcohol and cocaine/crack abuse but not with prescription medication use. This may result from harm reduction strategies available for opioid and benzodiazepine abuse. Appropriate administration of prescription opioids or benzodiazepines may be a useful strategy to increase appointment adherence, though this is complicated by the high prevalence of multi-substance use. Furthermore, a multidisciplinary, patient-centred approach to care with the utilisation of psychotherapy and pharmacotherapy helps engage patients in care and improve health outcomes for HIV-infected individuals (McHugh, Hearon, & Otto, 2010; Bruce, Kresina, & McCanceKatz, 2010 ).
Limitations
The retrospective study limited the data to private charts, leading to potential underreporting of substance use and difficulty in ascertaining multi-substance usage. The criteria for substance use were not based on standardised definitions due to chart limitations including prescription medication records. We recognise that some study participants on chronic opioids or benzodiazepines have medical indications for the medications; however, many patients anecdotally claimed to be abusing their prescriptions, prompting inclusion in the study.
Conclusion
This study has identified several substance use patterns and socio-demographic characteristics of HIV-infected persons in Manitoba. It is important to recognise vulnerable HIV-infected individuals in order to offer appropriate resources and support with the goal of increasing linkage to care and improving health outcomes for these individuals.
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